Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer
2021-09-16
0:00
34:49
Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
Fler avsnitt från "JAMA Oncology Author Interviews"
Missa inte ett avsnitt av “JAMA Oncology Author Interviews” och prenumerera på det i GetPodcast-appen.